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Abstract 
In Australia the spread of the Ostreid herpesvirus OsHV-1 microvariant (OsHV-1 µVar) threatens the 
Pacific oyster industry. There was an urgent need to develop an experimental infection model in 
order to study the pathogenesis of the virus in controlled laboratory conditions. The present study 
constitutes the first attempt to use archived frozen oysters as a source of inoculum, based on the 
Australian OsHV-1 µVar strain. Experiments were conducted to test (i) the virus infectivity, (ii) the 
dose-response relationship for OsHV-1, and (iii) the best storage conditions to keep infective viral 
inoculum. 
Intramuscular injection of a viral inoculum consistently led to an onset of mortality 48h post 
injection and a final cumulative mortality exceeding 90%, in association with high viral loads (1 x 
105 – 3 x 107 copies of virus mg-1) in dead individuals. For the first time an infective inoculum was 
produced from frozen oysters (tissues stored at -80°C for 6 months). Storage of purified viral 
inoculum at +4°C for 3 months provided similar results to use of fresh inoculum whereas storage at -
20°C, -80°C and room temperature was detrimental to infectivity. A dose-response relationship for 
OsHV-1 was identified but further research is recommended to determine the most appropriate viral 
concentration for development of infection models that would be used for different purposes. 
Overall, this work highlights the best practices and potential issues that may occur in the 
development of a reproducible and transferable infection model for studying the pathogenicity of 
the Australian OsHV-1 strain in C. gigas under experimental conditions. 
Keywords: Ostreid herpesvirus 1; Crassostrea gigas; experimental infection model; dose-response; 
inoculum preparation; storage conditions 
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Introduction 
Episodic herpes-like virus infections in Pacific oysters Crassostrea gigas have been reported in many 
European countries (France, United Kingdom, Jersey, Ireland, Spain and The Netherlands) and also in 
the United States of America (Renault 1994, Renault & Novoa 2004, Davison et al. 2005, Friedman 
2005, Schikorski, Renault, et al. 2011). Since 2008 mortality outbreaks have mainly been associated 
with the presence of a new herpesvirus strain (OsHV-1 µVar) infecting Pacific oysters during the 
summer period, concomitantly with a rapid increase of seawater temperature (Renault 2011).  
In late 2010, a few months after having decimated farms in bays on the North island of New Zealand, 
OsHV-1 µVar occurred for the first time in Australia in a small population of commercially farmed 
triploid Pacific oyster spat in Woolooware Bay within the Georges River/Botany Bay estuary, New 
South Wales (NSW) (Jenkins et al. 2013). In the present paper the term “OsHV-1” refers to OsHV-1 
µVar. Epidemiological investigations were conducted in Botany Bay in order to identify critical risk 
factors leading to mortality (Paul-Pont et al. 2013a, b). A little over two years later the first sign of 
spread of the virus was identified in the Hawkesbury River estuary (located 50 km north of Botany 
Bay) with OsHV-1 µVar related mass mortalities observed in commercial C. gigas leases (Paul-Pont et 
al. 2014). Due to the threat that OsHV-1 µVar poses to the entire Australian Pacific oyster industry, 
research activities were first directed towards (i) a mollusc breeding program to develop disease 
resistant Pacific oysters and (ii) the conduct of large-scale epidemiological investigations to identify 
the main risk factors for the disease outbreaks. In parallel, the development of a reproducible and 
transferable experimental infection model was crucial to study the virus and the mechanisms 
underlying infection and death in detail (pathogenicity, host immunity, risk factors). Indeed, 
important epidemiological features differ between the European and the Australian OsHV-1 µVar 
related mortality outbreaks (threshold temperature, window of infection, spatial and temporal 
distribution of mortality) (Pernet et al. 2012, Paul-Pont et al. 2013a, b, 2014), which underline the 
need to study the Australian OsHV-1 µVar strain in local controlled laboratory conditions.  
The present study describes the first experiments to set up a reproducible laboratory based 
experimental infection using the Australian OsHV-1 µVar strain purified from naturally infected 
oysters. Successful infection models using intramuscular injection that had already been developed 
in France (Schikorski, Faury, et al. 2011, Schikorski, Renault, et al. 2011) were used as a basis to 
develop a “local” infection model.  Four experimental infection trials were performed in order to test 
(i) the infectivity of the Australian OsHV-1 µVar strain using infected material sampled from the 
Georges River during the summer of 2011/2012 (experiments 1a and 1b), the dose-response 
relationship for OsHV-1 (experiment 2) and the best storage conditions to keep purified viral 
inoculums (experiment 3). Daily mortality was recorded for a period of 10 days. Viral concentrations 
in oyster tissues and seawater were also measured by real-time quantitative PCR during the time 
course of the experiments.  
 
Material and methods 
1. Experiments 
Four experiments were sequentially performed:  
- Experiments 1a and 1b: The aim was to assess whether the disease was reproducible in laboratory 
conditions using the Australian OsHV-1 µVar strain (temporally replicated experiments); 
- Experiment 2: The aim was to determine a dose-response relationship between the quantity of 
viral particles injected and the cumulative mortality of oysters;  
- Experiment 3: The aim was to identify the appropriate storage conditions required to maintain the 
viability of the Australian OsHV-1 µVar strain as a purified inoculum under laboratory conditions. 
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2. Origin of oysters and acclimation period 
All naive oysters used in this study were hatchery single seed triploid oysters (Shellfish Culture, 
Tasmania) and came from the same batch (11 month old; size 40-50 mm length). Naive oysters were 
harvested from Porto Bay in the Hawkesbury River (Oyster Leases 68/178 and 85/023), which had 
been free of OsHV-1 until 2013. Indeed, as part of another research project, a monitoring program 
was set up in the Hawkesbury River from September 2011 to September 2012 and confirmed the 
absence of OsHV-1 during this period (Paul-Pont et al., 2014). Additionally, n=30 oysters were 
sampled and tested negative for OsHV-1 using the TaqMan assay (Paul-Pont et al. 2013b) prior to 
each experiment.  
The oysters were harvested at different times depending on the experiment: July 2012 (Experiment 
1a), August 2012 (Experiments 1b and 2) and September 2012 (Experiment 3). Although no 
significant difference in size was observed in the oysters sampled from July to September (data not 
shown), it is reasonable to assume that oysters were not exactly identical among experiments as 
they aged over time. However as the sampling time of oysters was nested within experiment, there 
was no bias introduced in relation to the time of sampling. 
The oysters were transferred to the acclimation tanks within less than 12h after the sampling and 
the water temperature was set up to correspond to the environmental conditions in the field (15-
18°C) while the salinity was fixed at 30 ppt. The oysters were acclimatised for one week in 25 L tanks 
set up on a recirculation system connected to chillers, biofiltration and UV light. The water 
temperature in the tanks was increased by 1°C per day until it reached   22°C used during the 
experiments. Oysters were fed daily by addition of an adequate quantity (4 x 105 - 1.6 x 107 cells/ml) 
of shellfish diet 1800 (Instant Algae®, Reed Mariculture, USA) containing a mix of Isochrysis sp., 
Pavlova sp., Thalassiosira weissflogii and Tetraselmis sp. No mortality was recorded prior to the 
experiments.  
3. Inoculum preparation 
Oyster tissue homogenate from OsHV-1 μVar infected and non-infected Pacific oysters were used to 
prepare infected and control inoculums, respectively. OsHV-1 infected Pacific oysters (12 month old; 
length: 79.5 ± 4.6 mm, mean ± SD) were collected from the Georges River, NSW, Australia during a 
disease outbreak on the 24th November 2011. Control oysters (6 month old; length: 52.7 ± 8.8 mm, 
mean ± SD) were collected from the Hawkesbury River on the 19th December 2011. Both batches of 
oysters (i.e. infected and control) were previously tested by PCR to confirm their respective status 
(i.e. infected and control) and they were stored at -80 °C prior to being used for each experiment. 
For experiments 1 and 2 five oysters from each batch were removed from storage at -80°C one day 
prior to the commencement of the experiment and were thawed at 4°C overnight. The following 
day, each batch of 5 oysters was processed separately with sterile materials, and working benches 
were carefully disinfected with 1 % Virkon® between batches to prevent cross contamination. 
Oysters were opened by removing the superior valve, and a small piece of mantle (0.08-0.12 g) was 
sampled from each oyster and placed at -80°C before DNA extraction and OsHV-1 detection by real-
time PCR. The rest of the gills and mantle were dissected and pooled together (total weight: 10-12g) 
into a 50 mL sterile tube maintained in wet ice. These tissues were weighed and diluted by adding 10 
volumes of 0.22 µm filtered synthetic seawater (FSSW) to the tube. Tissues were homogenised using 
a MiniMix® stomaching machine (Crown Scientific, Australia) stomaching machine for one minute at 
maximum speed. After centrifugation (1000g, 5min, 4°C) supernatant was placed in a new sterile 
tube and diluted with 3 volumes of FSSW. Finally, the clarified tissue homogenate was filtered 
consecutively under aseptic conditions in a Class 2 Biosafety cabinet using syringe filters at 8 µm, 
0.45 µm and 2 x 0.22 µm pore sizes. The purified homogenate, or inoculum, was maintained on ice 
prior to the injection.  
For experiment 1 the inoculum was freshly prepared. Syringes containing 100 µL of each purified 
homogenate (control and infected) were prepared in the Class 2 Biosafety cabinet and maintained 
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on ice prior to the injection. The concentrations of the infected inoculums were 1.4 x 106 and 1.3 x 
107 viral DNA copies per ;mL in experiments 1a and 1 b respectively. No viral DNA was detected in 
the control inoculums. 
For experiment 2 the inoculum was freshly prepared and five concentrations were tested (pure at 5 
x 106 viral DNA copies per mL, and 10-fold serial dilutions: 10-1, 10-2, 10-3 and 10-4) in parallel with a 
control group. Accordingly, the pure inoculum was diluted 4 times with FSSW before being filtered 
twice using 0.22 µm pore sizes syringe filters prior to injection. Syringes containing 100 µL of each 
purified homogenate were prepared in the Class 2 Biosafety cabinet and maintained on ice prior to 
the injection.  
For experiment 3, the inoculum that had been freshly prepared in July 2012 (experiment 1) and 
dispensed into four tubes (5 mL) separately to be kept at room temperature (RT), +4°C, -20°C, -80°C 
and liquid nitrogen was used. In early October 2012 (+ 3 months) the different inoculums were 
thawed overnight at + 4°C (if required) and filtered twice using 0.22 µm pore sizes syringe filters 
prior to injection. Syringes containing 100 µL of each purified homogenate were prepared in the 
Class 2 Biosafety cabinet and maintained on ice prior to the injection. The viral DNA concentrations 
of each inoculum are listed in Table 2. 
4. Experimental infection 
Each intramuscular (IM) injection was carried out on the same day as the homogenate preparation, 
except for experiment 3 where stored inoculums were used.  
The IM injection was carried out using 8-10 oysters per treatment per 25L tank and was conducted 
in triplicate (n=3 replicate tanks containing a total n=30 oysters per treatment for experiments 1 and 
3, and n=24 oysters per treatment for experiment 2). Oysters were placed out of the water (air 
temperature 22°C) for 24h prior to immersion in a magnesium chloride solution (MgCl2; 50 g.L
-1) in 
seawater (1v)/distilled water (4v) for between 1 and 4 hours. Once relaxed, 100 µL of filtered tissue 
homogenate was injected into the adductor muscle of each oyster. The control and the infected 
oysters were injected on separated benches to prevent cross contamination and the inoculated 
oysters were put directly back in the water without any food supply or filtration system. This design 
ensured that (1) no water was shared among tanks due to recirculation; (2) the water temperature 
was uniform between tanks as it was controlled by equilibration with the air temperature (21.7 ± 1.2 
°C, mean ± SD). The salinity was monitored daily and stayed stable (30 ppt). Water quality 
parameters (ammonia, nitrate, nitrite, pH) were monitored daily. In experiment 1b the water was 
occasionally changed to maintain water quality in acceptable ranges. 
All experiments were conducted in a dedicated PC2 facility at the University of Sydney in accordance 
with the PC2 biosecurity regulations and protocols. 
5. Sampling strategy 
 A water sample was collected daily from each tank for PCR analysis (volume sampled=4mL, volume 
tested by PCR=200µL). Mortality was monitored daily for 10 days and no active sampling was 
performed on live oysters. Mean daily mortality ± SD was calculated among the three replicate 
tanks. Dead oysters were systematically removed from the tanks during the time course of the 
experiment and a piece of gill and mantle (0.08-0.12 g) was sampled from each dead individual. 
Control and surviving oysters were all sampled and sacrificed at the end of experiment. All tissue and 
water samples were frozen at -80°C prior to DNA extraction and OsHV-1 quantification by real-time 
PCR. 
6. Detection of OsHV-1 by real-time PCR in water and oyster tissues 
a. Tissue homogenisation 
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A piece of gills and mantle (0.08-0.12 g) was dissected from individual oysters using disposable 
sterile instruments that were changed between each oyster. After addition of 9 volumes of sterile 
distilled water, tissues were ground by bead-beating (Speed 6.5 m/sec; Time: 15 sec) (Fastprep 
System, MP Biosciences, USA). Tissue homogenates were then clarified by centrifugation at 900 × g 
for 10 min in a microcentrifuge. Clarified tissue homogenates were stored at − 80 °C until required. 
b. DNA extraction 
Viral DNA extraction was performed via magnetic beads using a MagMax-96 Viral RNA Isolation Kit 
(Ambion, USA) following the manufacturer’s recommended protocol, in a MagMax Express-96 
magnetic particle processor with disposable tip combs and standard 96-well processing plates 
(Appiled Biosystems, USA).  Extraction was performed on a 50 µL aliquot of clarified tissue 
homogenate and a 200 µL aliquot for water samples. 
c. Real-Time Polymerase Chain Reaction (PCR) 
The detection of OsHV-1 µVar DNA by real-time PCR was adapted from a previously published 
protocol (Martenot et al. 2010) and fully detailed in (Paul-Pont et al. 2013b). The detection limit was 
evaluated at 3 copies per mg of tissue and the quantification limit at 12 copies per mg of tissue 
based on guidelines previously published (Bustin et al. 2009, Martenot et al. 2010). A valid run was 
defined as a run exhibiting no amplification of the negative control, amplification of the positive 
control (Ct within the range of the standard curve) and a standard curve with r2 > 0.95 and efficiency 
between 90 and 110%. Threshold setting for each run was manually locked in based on the standard 
curve series. A sample was defined as positive when both replicates exhibited an exponential 
accumulation of fluorescence and a valid cycle threshold. 
7. Statistical analyses 
Summary statistics and box-and-whisker plots of time to mortality by treatment were initially 
created to make a preliminary assessment of the effect of infection on mortality. Kaplan Meier 
curves were created to compare survival between treatment groups for each experiment. Marginal 
cox models were then fitted to estimate hazard ratios after adjusting for the tank intra-cluster 
correlation. This approach uses a robust sandwich covariance matrix estimate to adjust for clustering 
(Lin, 1994). The proportional hazard assumption was evaluated graphically by creating log 
cumulative hazard plots and by testing time dependent covariates with log of time. Hazard ratios 
and their 95% confidence intervals were presented. All the analyses were conducted using SAS 
statistical program (© 2002-2010 by SAS Institute Inc., Cary, NC, USA) but the Kaplan-Meier curves 
were created using ggsurv function in R statistical package version 3.0.1 (© The R foundation for 
statistical computing).  
For the calculation of the mean viral copies/mg ± SD of tissues the authors firstly confirmed the 
absence of any significant tank effect (using an ANOVA test, p > 0.05; STATISTICA 10 software for 
Windows) before considering all replicate oysters, regardless of the tank number. 
 
Results 
1. Mortality 
During experiment 1a (July), oysters infected by intramuscular injection of OsHV-1 suspension were 
characterized by a sudden mortality reaching 70% at 48 hours post-injection (pi). At 72h pi, the 
cumulative mortality was 90% and reached 97% at 96h pi. Only one infected oyster survived and was 
eventually sacrificed at the end of the experiment (240 hours pi) for OsHV-1 quantification. The 
mortality of control oysters was nil, so all (n=30) were sacrificed and tested by real-time PCR at the 
end of the experiment. A similar pattern of mortality was observed in experiment 1b (August), with 
an onset of mortality 48h pi and a cumulative mortality of 96% was reached at 96h pi (Figure 1). All 
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OsHV-1 injected oysters were dead at 144h pi while no mortality was observed in the control group. 
The only difference in the mortality pattern between the two experiments concerned the cumulative 
mortality observed at 48h pi: 70% in experiment 1a and only 19% in experiment 1b, i.e. it was a little 
slower to commence in experiment 1b. Survival analysis indicated significant differences in survival 
probabilities between the two groups in both trials (p < 0.001) but hazard ratio confidence intervals 
could not be calculated due to nil mortality in control groups in both trials (Figure 1). 
In experiment 2 there was a clear dose-response relationship between the quantity of viral particles 
injected into the adductor muscle and the survival of oysters (Figure 1). Mortality was almost nil in 
the control group (one oyster died at 72h pi) and was therefore deleted for calculating hazard ratios. 
Mortality remained low in the highest dilution group (10-4) (two oysters died at 144 and 168h pi), 
while heavy mortalities reaching up to 88-96% were observed in the groups injected with pure 
inoculum or the lowest dilutions (10-1 and 10-2) (Figure 1). Dose response relationship was also 
evident from the hazard ratios presented in Table 1, which indicate that compared to the reference 
group injected with 5 x 102 copies per mL of virus, the other groups injected with greater quantities 
of virus had a greater hazard of death and the hazard was maximum in the group injected with 5 x 
106 copies of virus per mL.  
The survival analysis results for the experiment 3 are presented in Figure 1 and Table 1. The injection 
of the inoculum kept at +4°C for 3 months induced a significant mortality, similar to the mortality 
observed after injection of the fresh inoculum during the experiment . There was a cumulative 
mortality of 94% after 96h and 100% by the end of the experiment (240h pi). Survival in the +4°C 
group was significantly lower than all other groups with hazard ratios of 10.31 (95% confidence 
interval [CI]: 6.0, 17.8) compared to the room temperature group; 28.15 (95% CI: 18.5, 42.8) 
compared to the -20°C group; and 27.33 (95% CI: 12.4, 265.0) compared to the -80°C group (Figure 
1, Table 1). The hazard of death in the group injected with the inoculum kept at room temperature 
was significantly higher than the groups injected with inoculums kept at -80°C group (hazard ratio: 
5.56; 95% CI: 1.3, 24.1) and -20°C group (2.7; 95% CI: 2.0, 3.8). However, survival was not 
significantly different between -20°C and -80°C groups (Figure 1). These last two inoculums did not 
induce any substantial mortality as demonstrated by the cumulative mortalities of 3% and 7% at 10d 
pi, respectively. The injection of the inoculum kept in liquid nitrogen did not induce any mortality. 
No mortality was observed in the control group (Figure 1). Both of these groups were excluded for 
calculation of hazard ratios. 
2. Viral concentrations in oyster tissues and in seawater  
OsHV-1 was never detected in control oysters, confirming the absence of cross-contamination 
during the experiments.  
For experiment 1a the viral loads in dead oysters sampled during the first 96h post-injection, during 
which time 29 out of 30 oysters died, were between 3.7 x 105 and 2.5 x 107 copies mg-1 of tissue 
(Figure 2). As each oyster from the OsHV-1 group was injected with 100 µL of an inoculum of 1.4 x 
106 copies mL-1, the initial dose administered to these individuals was 1.4 x 105 copies. Viral loads 
measured in the dead individuals were much higher than the initial dose injected and thus confirm 
an efficient replication of viral particles in oyster tissues (Figure 2). The only infected survivor was 
sampled at the end of the experiment (240h pi) and presented a lower viral load in its tissue (1.1 x 
103 copies mg-1). Viral loads in infected tissues were significantly lower at 240h pi compared to all 
other time points (P<0.001). 
The viral concentrations in water increased from 9.0 x 104 to 1.8 x 106 copies mL-1 at 24 and 48h pi, 
respectively, before progressively decreasing to 2.5 x 102 copies mL-1 (Figure 2). For experiment 1b 
another PCR test (Pépin et al., 2008) was employed, therefore the data cannot be directly compared 
to the other experiments and are not presented in this paper. Even though occasional water changes 
at day 3 and 4 pi modified the viral loads in water, this did not affect the overall kinetics of infection 
recorded in oysters (data not shown).  
7 
 
For experiment 2, different concentrations of inoculum were administered ranging from 5.1 x  106 
(pure inoculum) to 5.1 x 102 (most diluted inoculum – 10-4) copies mL-1 in parallel to a control group 
injected with a virus-free inoculum. No virus was detected in the control group or in the oysters 
injected with the most diluted inoculum (inoculum 10-4). In all the other conditions (P, 10-1, 10-2, 10-3) 
the viral loads in dead oysters sampled during the experiment (i.e. all oysters sampled before 240h 
pi) were between 1.1 x 105 and 1.2 x 107 copies mg-1 regardless of the concentration of the inoculum 
used for the injections, except for one individual injected with  inoculum 10-2 (5.1 x 104 copies mL-1) 
sampled at 168h pi (viral load in tissue: 2.5 x 104 copies mg-1) (Figure 3). Similarly to experiment 1a, 
the viral loads measured in the surviving oysters actively sampled at 240h pi were much lower than 
the concentration measured in the dead individuals and in the corresponding inoculum (except for 
the surviving oysters injected with the inoculum 10-3) (Figure 3).  
The viral concentrations in seawater were relatively stable during the first 120h pi and were 
between 5.1 x 103 and 9.6 x 104 copies mL-1, regardless of the concentration of the initial inoculum. A 
decrease in the viral concentration in seawater was observed towards the end of the experiment (> 
120h pi) as the tanks were progressively emptied by removing the dead individuals.  
For experiment 3, the viral concentrations measured in the stored inoculums were systematically 
lower than the concentration measured in the fresh inoculum in July 2012 (1.3 x 106 copies mL-1), the 
lowest concentrations being found in the inoculums kept at room temperature and 4°C and the 
highest concentrations being observed in the frozen inoculums (-20 and -80°C) (Table 2). No viral 
DNA was detected in the dead (sampled during the time course of the experiment) and live (sampled 
at 240h pi) oysters injected with the viral inoculums kept at -20°C, -80°C and in liquid nitrogen. 
Among the five dead oysters that died up to 72h after having been injected with the inoculum kept 
at RT, three of them were negative for the viral DNA and the two remaining oysters demonstrated 
1.2 x 101 and 2.4 x 102 copies mg-1 (both were sampled at 48h pi). The only group that demonstrated 
significant mortalities corresponded to the oysters injected with the inoculum kept at +4°C (Figure 2) 
and the viral loads measured in the dead individuals varied between 6.7 x 105 and 3.0 x 107 copies 
mg-1 (Figure 4). The virus was only detected in the seawater of the tanks corresponding to the +4°C 
storage conditions and the concentrations were relatively stable over time, ranging from 2.2 x 103 to 
7.7 x 104 copies mg-1 (Figure 4). 
 
Discussion 
This work constitutes the first attempt to achieve a reproducible laboratory based experimental 
infection using the Australian OsHV-1 µVar strain purified from naturally infected oysters. It is the 
first report to confirm that OsHV-1 µVar remains viable in oyster tissues stored at -80°C, and such 
oysters can be used as a source of virus for infection trials.  
1. Mortality kinetics 
For all experiments intramuscular injections of pure viral inoculums prepared from Pacific oysters 
naturally infected by the Australian OsHV-1 µVar strain led to high cumulative mortalities (> 90% at 
the end of each experiment) associated with high viral loads in oysters. These results confirm active 
replication of the virus in experimentally infected animals as previously reported in other studies 
using the French OsHV-1 µVar strain (Schikorski, Faury, et al. 2011, Schikorski, Renault, et al. 2011, 
Segarra et al. 2014). Even though intramuscular injection does not reflect a “natural” infection as it 
overcomes the natural barriers (mucus, epithelia), this method was preferred over a cohabitation 
assay in order to obtain a standardized protocol, i.e. having all oysters infected at the same time 
with a similar dose of viral particles. The overall kinetics of mortality were similar among all 
individuals that had received a pure and fresh viral inoculum of similar concentration (1.3 – 5.1 x 106 
copies mL-1; Figures 1, 2, 3 and 4) with an onset of mortality at 48h pi and a cumulative mortality 
exceeding 90% after 7 days of exposure. This result is also in accordance with previous studies using 
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the intramuscular injection method and conducted on 7-12 month old Pacific oysters (Schikorski, 
Faury, et al. 2011, Segarra et al. 2014). No mortality was observed at 24h pi, which might be due to 
the time needed for viral replication in oyster tissues leading to irreversible cell damage and oyster 
mortality as suggested by Sauvage et al. (2009). Segarra et al. (2014) detected the presence of OsHV-
1 mRNAs in spat tissues as soon as 2, 4 and 18h post injection suggesting that the virus starts 
replicating in the early hours of the infection but the first mortalities were only observed at 42h pi.  
2. Dose-response effects  
A dose-response relationship between the concentration of viral particles in the inoculum and the 
percentage of mortality at 10d pi was identified through the results of the third experiment. Indeed, 
at 10d pi high cumulative mortalities (> 85%) were observed in oysters injected with concentrated 
inoculums (5.1 x 104 – 5.1 x 106 copies mL-1), while intermediate (63%) and insignificant (<10%) 
cumulative mortalities were recorded in oysters injected with less concentrated inoculum (5.1 x 103 
and 5.1 x 102 copies mL-1, respectively) (Figure 1). This result suggests that a sufficient initial dose of 
viral particles is needed to trigger high mortalities in Pacific oysters. Normand et al. (2014) showed 
great differences in mortality between two groups injected with a virulent and a non-virulent 
inoculum at 2 x 109 and 4 x 106 copies of viral genomes µL-1 and prepared from dying and apparently 
healthy oysters, respectively. However, it is unclear whether the differences in mortality were only 
due to the virulence of the virus or whether the concentration of the inoculum might also have 
played a role. In our experiment, the same inoculum was diluted serially 10 fold several times with 
FSSW and injected at the same time in all groups. Therefore it is clear that the differences in 
cumulative mortality were due only to the concentration of the inoculum and not to a potential 
difference in virulence. This result allows the identification of an appropriate inoculum 
concentration (1-5 x 103 copies mL-1) leading to slow mortality kinetics and intermediate cumulative 
mortality, which might be necessary in order to conduct research on the fine metabolic pathways in 
response to infection in live hosts prior to mortality, or to measure genetic effects. The study of viral 
or host transcripts is likely be modified in moribund/dead individuals due to degradation processes 
(Segarra et al. 2014).  
3. Mortality pattern: comparison with other studies 
Discrepancies occur in the literature when comparing the initial inoculum concentration and the 
mortalities obtained at 10d pi after intramuscular injection: Segarra et al. (2014) observed a 
cumulative mortality of 63% at 90h pi after the injection of 1.2 x 105 copies into 7 month old oysters; 
Normand et al. (2014) did not observe high mortalities (maximum cumulative mortality of 15% after 
7 days of challenge) after the injection of 2 x 109 copies into 8 month old oysters; and Schikorski et 
al. (2011) observed an extreme mortality (>90%) after the injection of 1.5 x 107 copies into 12 month 
old oysters, which is in accordance with the results of the first  two experiments presented in this 
paper. This variability in the short term mortality kinetics after intramuscular injection of a 
concentrated OsHV-1 inoculum highlights the potential issues and difficulties that may occur in the 
development of a reproducible and transferable infection model. Mainly, these issues concern (i) the 
variation in the natural host due to the utilization of different oyster batches for each experiment; 
(ii) the experimental parameters such as water renewal, density of infected host and nutrition; and 
(iii) the variation in the viral inoculum itself (strain, virulence). Natural variation in the resistance to 
pathogens, and particularly OsHV-1, is commonly observed in Pacific oyster populations and is 
mainly related to age, physiology, individual genetic basis and life history (Pernet et al. 2012, 
Dégremont 2013, Dégremont et al. 2013, Normand et al. 2014, Green et al. 2014). Additionally, the 
density of the infected population within a tank may also greatly affect the kinetics of the disease. In 
the present study a density of 8-10 oysters for 25 L of seawater (without food supply) was used 
whereas Normand et al. (2014) placed 40 infected oysters in 20L tanks in a flow-through system with 
food, and Schikorski et al. (2011) used 100 naive oysters in cohabitation with 40 moribund animals in 
25 L tanks. The water renewal regime was also different among studies. Therefore some 
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discrepancies between studies and/or infection trials seem quite inherent, and some precautions 
must be taken when comparing data from different studies. These discrepancies can also be 
explained by the variation in the viral inoculum itself (strain, virulence) as demonstrated by 
Normand et al. (2014) as well as by its conservation and stability over time, as demonstrated by the 
results of the third experiment.  
4. Storage conditions 
The storage of the viral inoculum at +4°C for a period of 3 months allowed the viral particles to 
remain highly infectious, as suggested by the high cumulative mortality obtained in this treatment, 
which was similar to the cumulative mortality obtained in July with the fresh inoculum (Figure 1). On 
contrary Corbeil et al., (2012a) demonstrated a loss of infectivity over time when the Abalone 
herpesvirus (AbHV) inoculum was held at +4°C. In addition, the authors mentioned that keeping 
AbHV inoculum in liquid itrogen prolongs viral infectivity for longer time periods (at least 21 months) 
than storage at -20°C and -80°C (Corbeil et al., 2012b). This is different from our results as the 
injection of OsHV-1 viral inoculums kept at room temperature, -20°C, -80°C and liquid nitrogen for 3 
months did not lead to any significant mortality (< 14%), regardless of the concentration of viral 
particles in each inoculum (Figure 1; Tables 1 and 2). However, as no cryoprotectant was employed 
here, this experiment should be repeated with additional treatments (i.e. test of a range of 
cryprotectants and protocols for progressive reduction of temperature). The experiment was 
purposely conducted without the use of cryoprotectant to compare with the success of the previous 
infection trials (experiments 1a and 1b) for which frozen oysters (temperature: -80°C; duration: 6 
months) were employed to prepare the viral inoculums. To our knowledge it is the first time that 
frozen tissues have been used as a source of infective viral particles; all previous studies with OsHV-1 
used fresh oysters collected from infected areas in the field or experimentally infected (Renault et al. 
2011, Schikorski et al. 2011, Schikorski, Renault, et al. 2011, Burge & Friedman 2012, Normand et al. 
2014, Green et al. 2014). The use of archived frozen oysters as source of infective particles 
constitutes a great step forward, allowing the conduct of experimental infections all year long even 
when the disease is not active in the field and fresh infected oysters are not available. This result 
also raises a question about the consequences of importing frozen oysters from infected 
areas/states/countries to non-infected locations: is this a possible means for spread of virus if 
infected frozen products may end up in coastal waters, for example through oysters being diverted 
from the human food chain to be used as bait, or shells being discarded in coastal waters from 
pleasure boats? Therefore studies are required to assess the viability of OsHV-1 in commercial fresh-
frozen oysters. 
5. OsHV-1 load in oysters tissues 
The viral concentrations measured in the gills and mantle of dead oysters collected during each 
infection trials were high and ranged between 1.1 x 105 and 3.0 x 107 copies mg-1, regardless of the 
infection trial, the time of collection and the initial concentration of viral particles in the inoculum, 
with a few exceptions (2 dead oysters from treatment 10-4 in experiment 2, and 1, 2 and 5 dead 
oysters from treatments “-80°C”, “-20°C” and “RT” in experiment 3, respectively). This result 
suggests that regardless of the time post infection and the quantity of viral particles injected into the 
animal, the quantity of viral particles must reach a threshold in oyster tissues before inducing death. 
This is consistent with previous field and lab studies demonstrating that viral concentrations 
exceeding 106 - 107 copies mg-1 are systematically associated with moribund/dying/dead oysters 
(Pepin et al. 2008, Oden et al. 2011, Paul-Pont et al. 2014). All oysters that survived the injections 
and were sacrificed alive at the end of the experiments (240h pi) demonstrated significantly lower 
viral concentrations in their tissues, below 3.1 x 103 copies mg-1, with a few exceptions (2 x 2 live 
oysters from treatments “10-3” and “10-1” in experiment 2). The low viral loads found in the survivors 
is in accordance with Oden et al. (2011) who defined a viral load threshold of 8.8 x 103 copies mg-1 
below which the risk of mortality due to the disease was null. 
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6. OsHV-1 variation in seawater 
During the first 24h the average viral concentrations in water increased from 0 (data not shown) to 
9.0 x 104 copies mL-1 in experiment 1a, 5.1 x 103, 1.6 x 104 and 1.7 x 104 copies mL-1  respectively in 
10-2, 10-1 and pure inoculum conditions in experiment 2, and 2.2 x 103 copies mL-1 in experiment 3 
(+4°C condition) (Figures 4, 5 and 6). Regardless of the infection trial or the initial concentration of 
viral particles in the inoculum, the average viral concentrations measured in water remained 
relatively stable over the first 120h and ranged between 2.2 x 103 and 1.8 x 106 copies mL-1. The 
decrease in viral concentrations in water observed towards the end of the experiments (>120h pi) 
were likely to be due to the progressive removal of the dead individuals. These results are in 
accordance with Schikorski et al. (2011) who demonstrated an increase in the viral concentrations in 
water up to 1 x 105 copies mL-1 during the 48h following the introduction of injected oysters to the 
tanks. A decrease in the viral concentration in water was also observed after the removal of the 
injected oysters.  
 
Conclusion 
In conclusion, the present work demonstrated that infection trials can be successfully developed in 
“local” conditions using the Australian OsHV-1µVar strain and healthy virus-free Pacific oysters from 
a non-infected estuary. However great precautions must be taken regarding (i) the source for the 
viral inoculum and its stability over time; (ii) the characteristics (age, physiology, genetics, life 
history) of the oysters used for the infection trials; and (iii) the experimental conditions (nutrition, 
infected host density, water renewal) in order to be able to develop a reproducible and transferable 
infection model. Conservation of the viral inoculum at +4°C provided the best outcome with similar 
cumulative mortality observed in comparison with the results of the first experiment performed 3 
months before with the fresh inoculum. A clear dose-response relationship for OsHV-1 was 
identified and further research is recommended to determine the most appropriate viral 
concentration to use for the development of an infection model for different purposes. Finally, for 
the first time an infective inoculum was produced from frozen oysters (-80°C for at least 6 months), 
thereby enabling infection trials to be conducted at any time of year. However, we raise a question 
about the potential for persistence of live OsHV-1 in fresh-frozen commercial oysters, and whether 
this could be a mean of translocation of virus. 
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Figures 
 
Figure 1. Survival analyses to compare mortality of Pacific oysters Crassostrea gigas exposed to 
different treatments in experiments 1a, 1b, 2 and 3.  
 
 
 
 
 
 
 
 
 
Experiment 1a Experiment 1b 
Experiment 2 Experiment 3 
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Figure 2. Viral loads in oyster gills (bars), seawater (unbroken line) and inoculum (dashed line) 
sampled in experiment 1a. All of the oysters sampledwere dead individuals that were systematically 
removed from the tanks, except for one live individual sampled at 240h post injection (black bar). 
Results are expressed as copies per mg for oyster tissues and copies per mL for seawater and 
inoculum (mean ± SD). The number above each bar represents the number of oysters analyzed at 
each time. 
 
 
 
 
 
 
Figure 3. Viral load in oyster gills (bars), seawater (unbroken line) and inoculum (dashed line) 
sampled in experiment 2. Different concentrations of viral inoculum were used: pure inoculum at 5.1 
x 106(a) and serial dilutions: 5.1 x 105 (b), 5.1 x 104(c) and 5.1 x 103(d) copies mL-1. All of the oysters 
sampled were dead individuals that were systematically removed from the tanks, except for the 
individuals sampled at 240h post injection (black bars). Results are expressed as copies per mg for 
oyster tissues and copies per mL for seawater and inoculum (mean ± SD). The number above each 
bar represents the number of oysters collected at each time. 
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Figure 4. Viral load in oyster gills (bars), water (unbroken line) and inoculum (dashed line) sampled in 
experiment 3. The inoculum was kept at +4°C for three months before being injected into naïve 
oysters. All of the oysters sampled were dead individuals that were systematically removed from the 
tanks.Results are expressed as copies per mg for oyster tissues and copies per mL for seawater and 
inoculum (mean ± SD). The number above each bar represents the number of oysters analyzed at 
each time. 
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Tables 
Table 1. Hazard ratios and their 95% confidence intervals based on the survival analyses conducted to 
compare hazard of death for the different treatment groups in experiments 2 and 3. 
Treatment groups 
Parameter  
estimate 
Standard  
error 
Hazard  
ratio 
95% CI of  
hazard ratio 
Experiment 2     
5 x 106 copies per mL 3.47 0.71 32.02 7.9, 129.2 
5 x 105 copies per mL 3.18 0.74 24.02 5.6, 102.2 
5 x 104 copies per mL 3.21 0.73 24.82 5.9, 104.3 
5 x 103 copies per mL 2.29 0.74 9.91 2.3, 41.9 
5 x 102 copies per mL* 0.00 0.00 1.00  
     
Experiment 3     
+4°C for 3 months 4.05 0.78 57.33 12.4, 265.0 
Room temperature 1.72 0.75 5.56 1.3, 24.1 
-20°C 0.71 0.73 2.04 0.5, 8.5 
-80°C 0.00 0.00 1.00  
 
 
 
Table 2. Viral concentrations in a fresh inoculum (prepared and analyzed in July 2012) and some 
aliquots kept at different storage temperature for 3 months (analyzed in October 2012). Results are 
expressed in OsHV-1 DNA copies per mL. 
Fresh inoculum Room temperature +4°C -20°C -80°C Liquid nitrogen 
1.4 x 106 6.4 x 102 7.1 x 103 3.1 x 105 3.1 x 105 6.9 x 103 
   
 
 
